Registry on local treatment methods for Myxoid Liposarcoma

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to prospectively evaluate various local treatment approaches for patients with Myxoid Liposarcoma (MLS). It will compare outcomes from different treatment modalities, including surgery and various radiation therapy doses, to confirm previous findings from the DOREMY trial. The study will collect and analyze data from multiple institutions to enhance understanding of effective treatment strategies for MLS.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age \> 18 years
* Biopsy proven MLS, including the reciprocal chromosomal translocation t(12;16)(q13;p11)
* ECOG PS 0-2
* Written informed consent to share coded information in this international Registry

Exclusion Criteria:

* Prior radiotherapy to the target area
* Pregnancy

Where it's running

• The Netherlands Cancer Institute
  Amsterdam, Netherlands Recruiting

Study contacts

• Principal investigator: Rick Haas, MD/PhD — The Netherlands Cancer Institute
• Study coordinator: Rick Haas, MD/PhD
• Email: r.haas@nki.nl
• Phone: +31 20 512 9111

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• N-803 for progressive synovial sarcoma and myxoid/round cell liposarcoma after TCR-T therapy

  This trial tests whether N-803 can safely boost lingering TCR-T immune cells and help people whose synovial sarcoma or myxoid/round cell liposarcoma has progressed after prior TCR-T treatment.

  Recruiting Early Phase 1 Northwestern University · Chicago, Illinois · NCT07261657

• Testing mirdametinib with palbociclib for treating liposarcoma

  This study is testing a new combination of two medications, mirdametinib and palbociclib, to see if they can help people with advanced liposarcoma feel better and improve their treatment options.

  Recruiting at 7 sites Phase 1/2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT06843967

• Evaluating treatments for non-rhabdomyosarcoma soft tissue sarcoma in young patients

  This study is testing a combination of chemotherapy and radiation to see if it helps young patients with non-rhabdomyosarcoma soft tissue sarcoma live longer without their cancer coming back.

  Recruiting at 7 sites Phase 1/2 St. Jude Children's Research Hospital · Atlanta, Georgia and 6 other locations · NCT06239272

• Exploring a new cancer treatment using PeptiCRAd-1 and checkpoint inhibitors

  This study is testing a new cancer treatment that combines a special virus with immune therapy to see if it can help people with advanced cancer who haven't responded to other treatments.

  Recruiting at 2 sites Phase 1 Valo Therapeutics Oy · Frankfurt and 6 other locations · NCT05492682

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.